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diameter, elevation of immunogloulins and cytokines levels
were observed in the groups treated with PZQ alone or
cmbined with PTX or silymarin.
In conclusion, in this study, treatment with PZQ
complemented with immunization resulted in signiﬁcant
reduction of parasitological parameters and rise of speciﬁc
Igs. Addition of antiﬁbrotic drugs PTX or silymarin to PZQ,
potentiated an antipathology effect which minimized and
ameliorated liver ﬁbrosis by inhibition of HSC activation and
accentuation of the effect of suppressor Treg cells.
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Objectives: Hand-foot-and-mouth disease (HFMD) is a highly
infectious disease which is mainly caused by enterovirus 71
(EV71) in China. Millions of children have been infected
by this virus in recent years, and the death toll is heavy.
Our study was focused on mapping EV71 speciﬁc linear
neutral epitopes and developing of new recombinant subunit
vaccine for HFMD.
Methods: The study included sera from 40 individuals
at different stages of disease. Twelve synthetic peptides
designed from EV71 VP1 protein were used to determine
antibody titers in an indirect enzyme-linked immunoassay.
The peptides had high antibody titers were chosen and
expressed in E. coli as a whole fusion protein. The fusion
protein was used to immunize Balb/c mice and 2 weeks
later the mice were sacriﬁced and collected the sera for
neutralization activity test to EV71.
Results: Four peptides of the twelve peptides had high
antibody titers in patient sera. Mice sera which were
immunized by the fusion protein of the four peptides had
neutral titer of 1:16 to 1:32.
Conclusion: The new recombinant fusion protein had a
good neutralization effect to EV71 virus and contained the
neutralization epitope(s). This protein is a candidate for
EV71 vaccine.
Acknowledgement: This study was supported by China
Postdoctoral Science Foundation, Shanghai Postdoctoral
Scientiﬁc Program and the Postdoctoral Fellowship Program
of Shanghai Institutes for Biological Sciences, Chinese
Academy of Sciences.
OL-039 Potential protection of OPV vaccination against
EV71 induced HFMD
C.Y. Deng1 *, C.F. Yang1, Q.B. Leng1. 1Institut Pasteur of
Shanghai, Chinese Academy of Sciences, China
Objective: Human Entervirus 71 (EV71) induced Hand Foot
and Mouth Disease (HFMD) is a common disease with high
morbidity in infants. Our study is to ﬁnd if Oral Poliovirus
Vaccine (OPV) immunization has any potential to protect
against EV71 infection and HFMD.
Methods: We collected data from 153 patients in mild and
sever group and selected 447 healthy children as controls.
We compared the two disease groups with the control group
with respect to OPV immunization schedule by c2 test to
determine whether immunization had any effect on the
EV71 infection and disease development.
Results: Children who had received the recommended OPV
immunization faced a lower risk of EV71 infection than
those whose didn’t. The low ratio of regular to irregular
OPV immunization among HFMD cases was mostly due
to the severe group with P value of less than 0.0001,
which indicated a signiﬁcant difference in the proportion
of children who had received the recommended OPV
immunization between the severe group and the control
group.
Conclusion: We found that regular OPV vaccination had
potential protection against EV71 induced HFMD, especially
for severe disease development. Our study suggests that
OPV vaccination is an alternative approach in controlling
EV71 induced HFMD.
Table 1. Comparison of recommended OPV immunization among mild,
severe and control groups in the Fuyang HFMD outbreaks of 2008
No. (ratio) Risk ratio (95%CI) Odds ratio (95%CI) P value
Controls (n = 447) 317 (70.9%)
All cases (n = 153) 88 (57.5%) 0.811 (0.699, 0.941) 0.555 (0.380, 0.812) 0.0023
Mild (n = 106) 68 (64.2%) 0.905 (0.775, 1.055) 0.734 (0.470, 1.147) 0.17
Severe (n = 47) 20 (42.6%) 0.600 (0.428, 0.841) 0.304 (0.165, 0.561) <0.0001
Severe vs. Mild 0.663 (0.462, 0.952) 0.414 (0.205, 0.835) 0.013
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Background: Angiogenesis is closely related with the
incidence and development of gastric cancer, but the
role of angiogenesis is still unknown in Helicobacter
pylori (H. pylori)-induced gastric cancer. This study is
to investigate the possible mechanism of gastric cancer
induced by H. pylori infection from the perspective of
angiogenesis.
Methods: C57BL/6 mouse gastric cancer model induced
by H. pylori infected was established by gavage with
H. pylori, and mice were divided into 2 groups: Control
group and Model group. After 72 weeks, Microvessel
density (MVD) in gastric mucosa was detected with
Evision immunohistochemical method. Vascular endothelial
growth factor (VEGF), Cyclooxygenase 2 (COX-2) mRNA and
protein expression were evaluated by real-time ﬂuorogenic
quantitative polymerase chain reaction (RFQ-PCR) and
immunohistochemical method, and the correlation between
COX-2 and VEGF were analyzed. Human gastric MKN45
cancer cells were infected with H. pylori, and the expression
of VEGF and COX-2 mRNA, protein were evaluated by
RFQ-PCR, Elisa and western blot. After inhibiting COX-2
expression and blocking p38MAPK pathway with COX-2
inhibitor NS398 and p38MAPK inhibitor SB203580, VEGF
expression was evaluated.
Result: This study reported C57BL/6 mouse gastric
adenocarcinoma model chronically colonized by H. pylori
is established successfully and H. pylori infection could
increase gastric mucosa MVD, and the expression of COX-2
mRNA, protein and VEGF mRNA, protein in Model group
were obviously increased than Control group. COX-2 mRNA
and protein was positively correlated to VEGF mRNA and
protein. The VEGF and COX-2 mRNA, proteins expression
levels increased remarkably with H. pylori stimulation in
the MKN45 gastric cancer cells. H. pylori also stimulated
phosphorylation of p38MAPK, and the expression levels of
VEGF and COX-2 were suppressed with SB203580 treatment
and VEGF were suppressed with NS398 treatment.
Conclusion: Helicobacter pylori induces C57BL/6 mice
gastric adenocarcinoma and enhances VEGF expression via
p38MAPK /COX-2 pathway.
